Bruker (BRKR) EBITDA Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -610.00 |
| Dec 31, 2025 | -1,554.00 |
| Sep 30, 2025 | -1,826.00 |
| Jun 30, 2025 | -649.00 |
| Mar 31, 2025 | 111.00 |
| Dec 31, 2024 | -314.00 |
| Sep 30, 2024 | 287.00 |
| Jun 30, 2024 | -491.00 |
| Mar 31, 2024 | -10.00 |
| Dec 31, 2023 | -711.00 |
| Sep 30, 2023 | -693.00 |
| Jun 30, 2023 | -339.00 |
| Mar 31, 2023 | 450.00 |
| Dec 31, 2022 | 53.00 |
| Sep 30, 2022 | -466.00 |
| Jun 30, 2022 | -581.00 |
| Mar 31, 2022 | -83.00 |
| Dec 31, 2021 | -456.00 |
| Sep 30, 2021 | 35.00 |
| Jun 30, 2021 | 749.00 |
| Mar 31, 2021 | -172.00 |
| Dec 31, 2020 | -237.00 |
| Sep 30, 2020 | 1,098.00 |
| Jun 30, 2020 | -681.00 |
| Mar 31, 2020 | -145.00 |
| Dec 31, 2019 | 1,924.00 |
| Sep 30, 2019 | 2,347.00 |
| Jun 30, 2019 | 801.00 |
| Mar 31, 2019 | 422.00 |
| Dec 31, 2018 | 681.00 |
| Sep 30, 2018 | 269.00 |
| Jun 30, 2018 | 144.00 |
| Mar 31, 2018 | 572.00 |
| Dec 31, 2017 | 1,582.00 |
| Sep 30, 2017 | 23.00 |
| Jun 30, 2017 | 1,409.00 |
| Mar 31, 2017 | 148.00 |
| Dec 31, 2016 | 505.00 |
| Sep 30, 2016 | 1,875.00 |
| Jun 30, 2016 | -807.00 |
| Mar 31, 2016 | -209.00 |
| Dec 31, 2015 | 238.00 |
| Sep 30, 2015 | -1,141.00 |
| Jun 30, 2015 | 220.00 |
| Mar 31, 2015 | -539.00 |